# Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

> **NCT02257008** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BILR 355 BS
- **OTHER:** Grapefruit juice
- **DRUG:** Nelfinavir
- **DRUG:** Atazanavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT02257008
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2003-12
- **Final completion:** —
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2014-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02257008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02257008, "Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02257008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*